Galmed Pharmaceuticals Unveils Potent Anti-Tumor Drug Synergy, Eyes Early-2026 Phase 1b Trial
Market Chameleon (Tue, 18-Nov 10:32 AM)
Galmed’s 3-Drug Combination Shows Enhanced Tumor Cell Killing: What the New Study Means for GI Cancer and the Future of Stivarga
Market Chameleon (Mon, 17-Nov 9:53 AM)
